Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrawound antibiotic powder in open extremity fractures
NCT04872400Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Jun 2021
- Primary completion
- Sep 2023
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vancomycin and tobramycin in surgical site infection (SSI), sponsored by University of Colorado Denver. Primary endpoint: Incidence of surgical site infection at 6 months. Started Jun 2021; status: completed.
02
Drugs
vancomycintobramycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04872400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04872400.